Cargando…
Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy. Diabetes 2009;58:934–945. DOI: 10.2337/db08-1287
Autores principales: | Francis, George, Martinez, Jose, Liu, Wei, Nguyen, Thuhien, Ayer, Amit, Fine, Jared, Zochodne, Douglas, Hanson, Leah R., Frey, William H., Toth, Cory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274693/ https://www.ncbi.nlm.nih.gov/pubmed/24757204 http://dx.doi.org/10.2337/db14-rt05a |
Ejemplares similares
-
Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035)
Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice.
Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID:
19696185
por: Prada, Patricia O., et al.
Publicado: (2017) -
Statement of Retraction. Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets. Diabetes 2008;57:645–653. DOI: 10.2337/db07-0847; and erratum. Diabetes 2014:63:3974. DOI: 10.2337/db14-er11
por: Shu, Luan, et al.
Publicado: (2017) -
Statement of Retraction. Nuts as a Replacement for Carbohydrates in the Diabetic Diet. Diabetes Care 2011;34:1706–1711. DOI: 10.2337/dc11-0338
por: Jenkins, David J.A., et al.
Publicado: (2016) -
Expression of Concern. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves
Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes
2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
por: Prada, Patricia O., et al.
Publicado: (2017) -
Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455
por: Berglund, Eric D., et al.
Publicado: (2016)